Text Registration
Copyright Title
Nitric oxide-release vehicles as oral disease therapeutics
Status
Published
on 28 Jan 2015
Year of Creation
2014
Copyright Claimant
Christopher James Backlund
Registration Number
TX0008074617
on 28 Jan 2015Copyright Summary
The U.S. Copyright record (Registration Number: TX0008074617) dated 28 Jan 2015, pertains to an electronic file (eService) titled "Nitric oxide-release vehicles as oral disease therapeutics" created in 2014. The copyright holder is Christopher James Backlund, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Christopher James Backlund.
Application Details
Registration Number
TX0008074617
Registration Date
1/28/2015
Year of Creation
2014
Agency Marc Code
DLC-CO
Record Status
New
Physical Description
Electronic Deposit
First Publication Nation
United States
Notes
Rights Note: Diana G Zajic, ProQuest-CSA, LLC, 789 E. Eisenhower Parkway, Ann Arbor, MI, 48108-3218, United States, (800) 521-0600 x7020, disspub@email.com
Statements
Application Title Statement: Nitric oxide-release vehicles as oral disease therapeutics
Author Statement: Christopher James Backlund Citizenship: not known Authorship: text
© 2023 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.